Sundown Osteo-Bi-Flex contributes to record Rexall quarter; revenues break $100 mil..
This article was originally published in The Tan Sheet
Executive Summary
REXALL SUNDOWN REVENUES INCREASE 83% TO $102.5 MIL. IN FIRST QUARTER, boosted by sales of the company's Osteo-Bi-Flex patented glucosamine/chondroitin combination formula, the dietary supplement manufacturer and distributor announced Dec. 17. Osteo-Bi-Flex, targeted to people with osteoarthritis and "creaky joints," recorded sales of $12 mil. in the quarter ended Nov. 30. The product is now the "third best-selling nutritional supplement" in the U.S., Boca Raton, Fla.-based Rexall Sundown said. In October, the company reported the supplement to be in the "top 10" of product sales in the nutritional category ("The Tan Sheet" Oct. 20, p. 17).